Correlation Between Adaptimmune Therapeutics and Mink Therapeutics
Can any of the company-specific risk be diversified away by investing in both Adaptimmune Therapeutics and Mink Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adaptimmune Therapeutics and Mink Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Adaptimmune Therapeutics Plc and Mink Therapeutics, you can compare the effects of market volatilities on Adaptimmune Therapeutics and Mink Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adaptimmune Therapeutics with a short position of Mink Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adaptimmune Therapeutics and Mink Therapeutics.
Diversification Opportunities for Adaptimmune Therapeutics and Mink Therapeutics
0.68 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Adaptimmune and Mink is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Adaptimmune Therapeutics Plc and Mink Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mink Therapeutics and Adaptimmune Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adaptimmune Therapeutics Plc are associated (or correlated) with Mink Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mink Therapeutics has no effect on the direction of Adaptimmune Therapeutics i.e., Adaptimmune Therapeutics and Mink Therapeutics go up and down completely randomly.
Pair Corralation between Adaptimmune Therapeutics and Mink Therapeutics
Given the investment horizon of 90 days Adaptimmune Therapeutics Plc is expected to under-perform the Mink Therapeutics. In addition to that, Adaptimmune Therapeutics is 2.03 times more volatile than Mink Therapeutics. It trades about -0.18 of its total potential returns per unit of risk. Mink Therapeutics is currently generating about -0.1 per unit of volatility. If you would invest 82.00 in Mink Therapeutics on August 23, 2024 and sell it today you would lose (13.00) from holding Mink Therapeutics or give up 15.85% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Adaptimmune Therapeutics Plc vs. Mink Therapeutics
Performance |
Timeline |
Adaptimmune Therapeutics |
Mink Therapeutics |
Adaptimmune Therapeutics and Mink Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Adaptimmune Therapeutics and Mink Therapeutics
The main advantage of trading using opposite Adaptimmune Therapeutics and Mink Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adaptimmune Therapeutics position performs unexpectedly, Mink Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mink Therapeutics will offset losses from the drop in Mink Therapeutics' long position.The idea behind Adaptimmune Therapeutics Plc and Mink Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Mink Therapeutics vs. Affimed NV | Mink Therapeutics vs. Adaptimmune Therapeutics Plc | Mink Therapeutics vs. Sangamo Therapeutics | Mink Therapeutics vs. Day One Biopharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Complementary Tools
Global Correlations Find global opportunities by holding instruments from different markets | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |